Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM256P1 is classified as a pseudogene on chromosome 10q22.1 (NCBI Gene ID: 645269). Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of gene expression; they do not encode active proteins or functional RNA products[1][4]. There is no evidence in current scientific literature for TMEM256P1 encoding a receptor, enzyme, transporter, or other therapeutic target class. It does not have established functions in biological pathways, disease roles, or drug interactions[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 256 pseudogene 1 (TMEM256P1).